Refine your search
17 trials found for "Breast cancer", "Breast Neoplasm"
Recruiting
Not yet recruiting
Recruiting
NCT03445637
Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®
Breast Neoplasm
Females
18+ years
1study location(s)
Recruiting
NCT04654208
Swedish Ibrance Registries Insights (SIRI)
Malignant Neoplasm of Breast
Male or Female
18 - 99 years
1study location(s)
Recruiting
NCT04937660
Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
Metastatic Breast Cancer
Male or Female
18 - 90 years
12study location(s)
Oct 01, 2025 - Planned start date (Not yet recruiting)
NCT07174336
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Male or Female
18+ years
30study location(s)
Sep 09, 2025 - Planned start date (Not yet recruiting)
NCT07160738
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
Healthy Adults
Male or Female
18 - 65 years
Dec 01, 2026 - Planned start date (Not yet recruiting)
NCT06873191
A Study to Learn More About Tukysa Once it is Out in the Korean Market
HER2-positive Locally Advanced Unresectable, Metastatic Breast Cancer
Male or Female
18+ years
Jun 30, 2025 - Planned start date (Not yet recruiting)
NCT06962969
A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database
Advanced or Metastatic Breast Cancer
Females
18+ years
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.